[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CO5160291A1 - Composicion farmaceutica topica que contiene 4-(2,4-dihidroxifenil) ciclohexanol - Google Patents

Composicion farmaceutica topica que contiene 4-(2,4-dihidroxifenil) ciclohexanol

Info

Publication number
CO5160291A1
CO5160291A1 CO00020443A CO00020443A CO5160291A1 CO 5160291 A1 CO5160291 A1 CO 5160291A1 CO 00020443 A CO00020443 A CO 00020443A CO 00020443 A CO00020443 A CO 00020443A CO 5160291 A1 CO5160291 A1 CO 5160291A1
Authority
CO
Colombia
Prior art keywords
pharmaceutical composition
dihydroxifenil
cyclhexanol
topica
skin
Prior art date
Application number
CO00020443A
Other languages
English (en)
Inventor
Eric William Collington
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO5160291A1 publication Critical patent/CO5160291A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/03—Liquid compositions with two or more distinct layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una composición farmacéutica tópica para aclarar la piel o reducir la pigmentación de la piel en un ser humano, que comprende una cantidad de un compuesto de fórmula(I):<EMI FILE="00020443_1" ID="1" IMF=JPEG >o una sal farmacéuticamente aceptable del mismo, siendo dicha cantidad eficaz para aclarar la piel o reducir la pigmentación de la piel, y un vehículo farmacéuticamente aceptable.
CO00020443A 1999-03-22 2000-03-22 Composicion farmaceutica topica que contiene 4-(2,4-dihidroxifenil) ciclohexanol CO5160291A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12555399P 1999-03-22 1999-03-22

Publications (1)

Publication Number Publication Date
CO5160291A1 true CO5160291A1 (es) 2002-05-30

Family

ID=22420269

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00020443A CO5160291A1 (es) 1999-03-22 2000-03-22 Composicion farmaceutica topica que contiene 4-(2,4-dihidroxifenil) ciclohexanol

Country Status (45)

Country Link
EP (1) EP1165031B1 (es)
JP (1) JP2002539234A (es)
KR (1) KR100468250B1 (es)
CN (1) CN1213726C (es)
AP (1) AP1413A (es)
AR (1) AR018475A1 (es)
AT (1) ATE297187T1 (es)
AU (1) AU765209B2 (es)
BG (1) BG65146B1 (es)
BR (1) BR0009194A (es)
CA (1) CA2366623C (es)
CO (1) CO5160291A1 (es)
CR (1) CR6452A (es)
CZ (1) CZ298939B6 (es)
DE (1) DE60020682T2 (es)
DZ (1) DZ3022A1 (es)
EA (1) EA003866B1 (es)
EE (1) EE200100489A (es)
ES (1) ES2241580T3 (es)
GE (1) GEP20043231B (es)
GT (1) GT200000030A (es)
HK (1) HK1044478B (es)
HN (1) HN2000000033A (es)
HR (1) HRP20010696A2 (es)
HU (1) HUP0200684A3 (es)
ID (1) ID30272A (es)
IL (1) IL144848A0 (es)
IS (1) IS6052A (es)
MA (1) MA26726A1 (es)
MY (1) MY133193A (es)
NO (1) NO20014586L (es)
NZ (1) NZ513453A (es)
OA (1) OA11840A (es)
PA (1) PA8492001A1 (es)
PE (1) PE20001567A1 (es)
PL (1) PL350905A1 (es)
PT (1) PT1165031E (es)
SK (1) SK285434B6 (es)
TN (1) TNSN00055A1 (es)
TR (1) TR200102741T2 (es)
TW (1) TWI224011B (es)
UY (1) UY26072A1 (es)
WO (1) WO2000056279A1 (es)
YU (1) YU67101A (es)
ZA (1) ZA200106681B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816843B1 (fr) * 2000-11-23 2006-10-27 Actichem Inhibiteurs de l'enzyme 5 alpha-reductase
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
DE10324566A1 (de) * 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
FR2894582B1 (fr) 2005-12-12 2008-02-22 Fabre Pierre Dermo Cosmetique Sirna anti myosine va et depigmentation de la peau
FR2939136B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2016131824A1 (en) * 2015-02-16 2016-08-25 Xantial Composition for prevention or treatment of cutaneous disorder
EP3322291B1 (en) 2015-07-14 2023-04-12 Unilever IP Holdings B.V. Antimicrobial composition
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.

Also Published As

Publication number Publication date
KR20010114233A (ko) 2001-12-31
EE200100489A (et) 2002-12-16
AR018475A1 (es) 2001-11-14
GT200000030A (es) 2001-09-08
PE20001567A1 (es) 2001-01-13
PL350905A1 (en) 2003-02-10
HK1044478B (zh) 2005-12-09
EP1165031A1 (en) 2002-01-02
HUP0200684A3 (en) 2009-11-30
PT1165031E (pt) 2005-09-30
CN1344152A (zh) 2002-04-10
DZ3022A1 (fr) 2004-03-27
ID30272A (id) 2001-11-15
HUP0200684A2 (en) 2002-08-28
NO20014586D0 (no) 2001-09-21
HK1044478A1 (en) 2002-10-25
JP2002539234A (ja) 2002-11-19
DE60020682D1 (de) 2005-07-14
UY26072A1 (es) 2000-10-31
TNSN00055A1 (fr) 2005-11-10
BG106016A (en) 2002-05-31
HN2000000033A (es) 2001-02-02
CA2366623C (en) 2006-06-13
EP1165031B1 (en) 2005-06-08
IS6052A (is) 2001-08-17
SK285434B6 (sk) 2007-01-04
GEP20043231B (en) 2004-05-25
BG65146B1 (bg) 2007-04-30
AU765209B2 (en) 2003-09-11
TR200102741T2 (tr) 2002-01-21
ZA200106681B (en) 2002-08-14
KR100468250B1 (ko) 2005-01-27
ES2241580T3 (es) 2005-11-01
TWI224011B (en) 2004-11-21
CA2366623A1 (en) 2000-09-28
EA003866B1 (ru) 2003-10-30
PA8492001A1 (es) 2002-02-21
CZ20013339A3 (cs) 2002-07-17
IL144848A0 (en) 2002-06-30
AP1413A (en) 2005-03-18
EA200100853A1 (ru) 2002-02-28
NZ513453A (en) 2003-04-29
OA11840A (en) 2005-08-22
CR6452A (es) 2004-03-24
YU67101A (sh) 2004-12-31
AU2823000A (en) 2000-10-09
BR0009194A (pt) 2001-12-18
HRP20010696A2 (en) 2002-08-31
CN1213726C (zh) 2005-08-10
AP2001002273A0 (en) 2001-09-30
NO20014586L (no) 2001-11-21
ATE297187T1 (de) 2005-06-15
CZ298939B6 (cs) 2008-03-19
MA26726A1 (fr) 2004-12-20
WO2000056279A1 (en) 2000-09-28
SK13222001A3 (sk) 2002-08-06
DE60020682T2 (de) 2006-04-06
MY133193A (en) 2007-10-31

Similar Documents

Publication Publication Date Title
CO5070677A1 (es) Composicion topica para aclarar o reducir la pigmentacion que contiene derivados de resorcinol
CO5570109A1 (es) Compuestos de dihidropirimidina heterociclicos
CO5271657A1 (es) Derivados de azaindol
CO5180581A1 (es) Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
DE69327536D1 (de) Fibrinogenrezeptor-antagonisten
CO5111023A1 (es) Composicion de articulo absorbente y metodo para usarla para secuestrar irritantes de la piel
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
CO5251404A1 (es) Compuestos antibioticos de azalida
SE9504661D0 (sv) New compounds
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
MY119403A (en) Novel compounds with analgesic effect.
GEP20033079B (en) Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency
MXPA05003302A (es) Compuestos de piperazina terapeuticos.
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
SE9900961D0 (sv) Novel compounds
CO5160291A1 (es) Composicion farmaceutica topica que contiene 4-(2,4-dihidroxifenil) ciclohexanol
RU94044456A (ru) Средство для подавления дисфункционального маточного кровотечения
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
BRPI0406832A (pt) Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
CO5150193A1 (es) DIHIDROXIACIDO ABIERTO Y SALES DE INHIBIDORES DE LA HMG-CoA REDUCTASA
SE9802209D0 (sv) Novel compounds